STOCK TITAN
  1. Home
  2. News
  3. ZTS

Zoetis Inc - ZTS STOCK NEWS

Welcome to our dedicated news page for Zoetis (Ticker: ZTS), a resource for investors and traders seeking the latest updates and insights on Zoetis.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zoetis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zoetis's position in the market.

News
Zoetis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Zoetis Inc. (NYSE:ZTS) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. Investors and other interested parties can access a live audio webcast of the presentation on http://investor.zoetis.com/events-presentations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
conferences
-
News
Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase
Rhea-AI Summary
Zoetis Inc. (ZTS) declares a dividend of $0.432 per share for the first quarter of 2024, an increase of 15% from 2023. The dividend will be paid on March 1, 2024, to all holders of record of the Company’s common stock as of January 19, 2024. Executive Vice President and CFO Wetteny Joseph attributes the increase to Zoetis' strong performance and commitment to returning excess capital to shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
dividends earnings
-
News
Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference
Rhea-AI Summary
Zoetis Inc. (ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023. Wetteny Joseph, EVP and CFO, will represent the company. Investors can access a live webcast of the presentation on the Zoetis website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
conferences
News
Petco Love Announces Newest Board Members
Rhea-AI Summary
Petco Love: Bolsters Board to Better Serve Pet Lovers Nationwide - Welcomes New Members to Support Lifesaving Mission
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.26%
Tags
management
-
News
Zoetis Announces Third Quarter 2023 Results
Rhea-AI Summary
Zoetis Inc. reports revenue of $2.2 billion, growing 7% in Q3 2023. Net income increases 13% to $596 million. Adjusted net income reaches $629 million, a 13% increase. Full-year 2023 revenue guidance range updated to $8.475 - $8.550 billion. Operational revenue growth guidance narrowed to 6.5% - 7.5% and adjusted net income growth to 7.5% - 8.5%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
earnings
-
News
Zoetis Declares Fourth Quarter 2023 Dividend
Rhea-AI Summary
Zoetis Inc. declares $0.375 per share dividend for Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
dividends earnings
News
Zoetis Named a 100 Best Company for Working Parents by Seramount
Rhea-AI Summary
Zoetis named one of Seramount's 100 Best Companies for Working Parents for the tenth year in a row
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
none
-
News
Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results
Rhea-AI Summary
Zoetis Inc. will host a webcast and conference call to review Q3 2023 financial results on Nov. 2, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
conferences earnings
-
News
Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for Veterinarians and Livestock Farmers
Rhea-AI Summary
The Zoetis Foundation will distribute $2.6 million in grants to support initiatives in Australia, Brazil, the UK, and the US. The grants will focus on veterinary scholarships and debt relief, mental well-being, diversity and inclusion, and livestock farmers' livelihoods. The Foundation is expanding its support for veterinary mental health and wellness. The grants will provide financial support and resources to veterinary professionals and farmers, addressing important issues such as student debt and mental health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
none
News
Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Rhea-AI Summary
Zoetis Inc. to participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Sept. 12, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
conferences
Stock ZTS logo
Zoetis Inc

NYSE:ZTS

ZTS Rankings

#176 Ranked by Market Cap
#1796 Ranked by Stock Gains
#1769 Ranked by Dividends

ZTS Stock Data

68.53B
456.86M
0.23%
95.6%
0.8%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Parsippany

About ZTS

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.